Understanding T Cells in Brain Disorders
The 2nd International "T Cells in the Brain (TCB2025): Decoding T Cell Targets in Neurodegeneration"
This study is looking at how T cells, a type of immune cell, might affect brain diseases like Alzheimer's and ALS, and it brings together different experts to share ideas and find new ways to help treat these conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11000638 on NIH RePORTER |
What this research studies
This research focuses on the role of T cells in neurodegenerative diseases, particularly how they contribute to conditions like Alzheimer's and ALS. It aims to bring together experts from various fields to share knowledge and collaborate on identifying T cell targets for potential therapies. By fostering interdisciplinary discussions, the project seeks to enhance our understanding of T cell behavior in the brain and develop new treatment strategies. The initiative also emphasizes inclusivity by encouraging participation from diverse researchers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with neurodegenerative diseases such as Alzheimer's disease or ALS.
Not a fit: Patients with non-neurodegenerative conditions or those not affected by T cell-related immune responses may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic interventions targeting T cells, potentially improving outcomes for patients with neurodegenerative diseases.
How similar studies have performed: Previous research has shown promising results in understanding T cell roles in neuroinflammation, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Elyaman, Wassim — Columbia University Health Sciences
- Study coordinator: Elyaman, Wassim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.